Short-term administration of Polypodium leucotomos extract does not inhibit CYP3A4-mediated metabolism of midazolam in healthy subjects: an open-label, two-period, fixed-sequence study., Shinya Koichiro;Nishimura Yuki;Ryu Kakei;Sambe Takehiko;Fujishiro Masaya;Nakauchi Akihiro;Kashiwabuchi Yumika;Iwase Mariko;Chokki Hirokazu;Kurata Norimitsu;Matsuyama Takaaki;Kiuchi Yuji, International journal of dermatology,
62(5):694 - 699, May 2023,
Peer-reviewed,
DOI:10.1111/ijd.16303 Lack of inhibitory effect of wood creosote on cytochrome P450‐mediated drug metabolism, Hirokazu Chokki; Yuki Nishimura; Mariko Iwase; Norimitsu Kurata; Koichiro Shinya; Mayumi Tsuji; Masafumi Ito; Mutsumi Asai; Hirofumi Morino; Takanori Miura; Takashi Shibata; Yuji Kiuchi, Traditional & Kampo Medicine, 9(1):3 - 9, Apr. 2022, Peer-reviewed
Inhibition of CYP3A-mediated Midazolam Metabolism by Kaempferia Parviflora., Kashiwabuchi Yumika;Nishimura Yuki;Kurata Norimitsu;Iwase Mariko;Kiuchi Yuji;Nobe Koji, Food safety, 10(1):32 - 41, Mar. 2022, Peer-reviewed
Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38., Mariko Iwase; Ken-Ichi Fujita; Yuki Nishimura; Natsumi Seba; Yusuke Masuo; Hiroo Ishida; Yukio Kato; Yuji Kiuchi, Cancer chemotherapy and pharmacology,
83(5):993 - 998, May 2019,
Peer-reviewed,
DOI:10.1007/s00280-019-03784-8 Inhibitory Effect of Polypodium Leucotomos Extract on Cytochrome P450 3A-mediated Midazolam Metabolism, GOMI Yurika;NISHIMURA Yuki;KURATA Norimitsu;IWASE Mariko;SHINYA Koichiro;KIUCHI Yuji, The Showa University Journal of Medical Sciences,
31(1):29 - 39, Mar. 2019,
Peer-reviewed,
DOI:10.15369/sujms.31.29 Effect of benifuuki tea on cytochrome P450-mediated metabolic activity in rats, Takahito Hirai; Yuki Nishimura; Norimitsu Kurata; Hokuto Namba; Mariko Iwase; Yurika Gomi; Hiromichi Tsuchiya; Tomoyuki Yamakawa; Yuji Kiuchi, In Vivo, 32(1):33 - 40, Jan. 2018, Peer-reviewed
Inhibitory Effects of Gastrointestinal Drugs on CYP Activities in Human Liver Microsomes, Iwase Mariko;Nishimura Yuki;Kurata Norimitsu;Namba Hokuto;Hirai Takahito;Kiuchi Yuji, Biological and Pharmaceutical Bulletin,
40(10):1654 - 1660, Oct. 2017,
Peer-reviewed,
DOI:10.1248/bpb.b17-00118 Evaluation of CYP2D6 Protein Expression and Activity in the Small Intestine to Determine Its Metabolic Capability in the Japanese Population, Kawakami Momoko;Takenoshita-Nakaya Sachiko;Takeba Yuko;Nishimura Yuki;Oda Masayuki;Watanabe Minoru;Ohta Yuki;Kobayashi Shinjiro;Ohtsubo Takehito;Kobayashi Shinichi;Uchida Naoki;Matsumoto Naoki, Biological and Pharmaceutical Bulletin,
40(9):1344 - 1351, Sep. 2017,
Peer-reviewed,
DOI:10.1248/bpb.b16-00370 Inhibitory Effect of Oxethazaine on Midazolam Metabolism in Rats, Namba Hokuto;Nishimura Yuki;Kurata Norimitsu;Iwase Mariko;Hirai Takahito;Kiuchi Yuji, Biological and Pharmaceutical Bulletin,
40(9):1361 - 1365, Sep. 2017,
Peer-reviewed,
DOI:10.1248/bpb.b16-01016 OBJECTIVE AND SUBJECTIVE EVALUATIONS TO DETERMINE THE MIDAZOLAM OPTIMAL DOSE IN THE DENTAL TREATMENT, KONDO Keisuke; IKEDA Miyuki; SAMBE Takehiko; UCHIDA Naoki; IWASE Mariko; NISHIMURA Yuki; MANABE Atsuhumi; RYU Kakei; KOBAYASHI Shinichi; INADA Yoko, Journal of The Showa University Society,
75(6):665 - 674, Dec. 2015,
Peer-reviewed,
DOI:10.14930/jshowaunivsoc.75.665 Inhibition of CYP3A4-mediated midazolam metabolism by repeat oral administration of Anchusan in humans, Hirokazu Toshima; Takehiko Sanbe; Junichiro Kizaki; Katsuji Oguchi; Naoki Uchida; Yuki Nishimura; Mariko Iwase; Yoshie Harimoto; Momoko Kawakami; Makiko Hirosawa; Shinichi Kobayashi, Journal of the Showa Medical Association,
73(2):120 - 128, Apr. 2013,
Peer-reviewed,
DOI:10.14930/jshowaunivsoc.73.120 Effect of the short-term anchusan treatment on CYP3A4-mediated midazolam metabolism in healthy subjects, Takehiko Sambe; Yuki Nishimura; Naoki Uchida; Hirokazu Toshima; Mariko Iwase; Yoshie Harimoto; Momoko Kawakami; Kakei Ryu; Yoshito Kobayashi; Yasuyuki Kondo; Katsuji Oguchi; Shinichi Kobayashi, Journal of the Showa Medical Association,
73(2):67 - 75, Apr. 2013,
Peer-reviewed,
DOI:10.14930/jshowaunivsoc.73.67 In vivo inhibition of CYP3A-mediated midazolam metabolism by anchusan in rats., Yusuke Saito; Yuki Nishimura; Norimitsu Kurata; Mariko Iwase; Kayo Aoki; Hajime Yasuhara, Journal of pharmacological sciences, 115(3):399 - 407, 2011
Effects of continuous ingestion of herbal teas on intestinal CYP3A in the rat, Kazuhiro Matsuda; Yuki Nishimura; Norimitsu Kurata; Mariko Iwase; Hajime Yasuhara, JOURNAL OF PHARMACOLOGICAL SCIENCES, 103(2):214 - 221, Feb. 2007
Inhibitory effect of antituberculosis drugs on human cytochrome P450-mediated activities., Yuki Nishimura; Norimitsu Kurata; Eriko Sakurai; Hajime Yasuhara, Journal of pharmacological sciences, 96(3):293 - 300, Nov. 2004
日本人健康成人男性におけるブラックジンジャー反復投与時のCYP3A4を介するミダゾラム代謝に及ぼす影響, 三邉 武彦;諸星 北人;西村 有希;龍 家圭;肥田 典子;山崎 太義;岩瀬 万里子;倉田 知光;五味 由梨佳;木内 祐二;小林 真一;内田 直樹, 第40回日本臨床薬理学会学術総会, 04 Dec. 2019, 東京
Inhibitory effects of black ginger extract on CYP3A-mediated midazolam metabolism., NISHIMURA Yuki;KURATA Norimitsu;IWASE Mariko;GOMI Yurika;KASHIWABUCHI Yumika;KIUCHI Yuji, 2018 International Meeteing on 22nd MDO and 33rd JSSX, 02 Oct. 2018, Kanazawa
Inhibitory effect of Polypodium leucotomos extract on CYP3A-mediated midazolam metabolism, GOMI Yurika;NISHIMURA Yuki;KURATA Norimitsu;IWASE Mariko;KIUCHI Yuji, The 18th World Congress of Basic and Clinical Pharmacology (WCP2018), 03 Jul. 2018, Kyoto
Effect of Benifuuki tea on cytochrome P450s in rats., 平井隆仁,西村有希,倉田知光,難波北人,岩瀬万里子, 小口勝司., 第89回日本薬理学会年会, 10 Mar. 2016, 神奈川
Effect of Benifuuki tea on cytochrome P450s in rats., 平井隆仁,西村有希,倉田知光,難波北人,岩瀬万里子, 小口勝司., 第89回日本薬理学会年会, 10 Mar. 2016, 神奈川
べにふうき茶反復投与のラットチトクロームP450に対する影響, 平井隆仁,西村有希,倉田知光,難波北人,岩瀬万里子, 小口勝司., 第36回日本臨床薬理学会学術総会, 11 Dec. 2015, 東京
The estimation of drug interaction by pazopanib through the inhibition of UDP-glucuronosyltransferase (UGT) 1A1, IWASE Mariko;FUJITA Ken-ichi;NISHIMURA Yuki;OGUCHI Katsuji, 日本薬物動態学会第30回年会, 13 Nov. 2015, 東京
Assessment of potential factors related to low CYP2C19 activity in liver cancer patients, NISHIMURA Yuki;KURATA Norimitsu;IWASE Mariko;YASUHARA Rika;YASUHARA Hajime;KOBAYASHI Yasuna;YAMAMOTO Toshinori;AOKI Takeshi;MURAKAMI Masahiko;SAITO Koji;KOBAYASHI Shinichi;OGUCHI Katsuji, 19th North American ISSX Meeting and 29th JSSX Meeting, 20 Oct. 2014, San Francisco
The inhibitory effects of gastrointestinal and respiratory drugs on human hepatic microsomal cytochrome P450 activities., IWASE Mariko, 19th North America ISSX and 29th JSSX meeting, 19 Oct. 2014, San Francisco
Drug-drug interaction with OTC drugs ~The inhibitory effect of NSAIDs and cough suppressants on CYP activities., IWASE Mariko;NISHIMURA Yuki;KURATA Norimitsu;UCHIDA Naoki;KOBAYASHI Shinichi, 6th European Congress of Pharmacology, 17 Jul. 2012, Granada